Skip to main content

Forus

Forus provides an AI-powered platform that automates the administrative steps between a prescription and a patient starting treatment, including prior authorizations, appeal letters, pharmacy routing, and financial assistance enrollment. The platform is free for doctors and patients, works with any EHR, and supports every drug, insurance, and pharmacy across all 50 states, reducing prior authorization turnaround times to a median of 1.1 days.

Traction –/10
New York, United States · HQ
24020K+ followers
  • Healthcare Technology
  • Digital Health
  • Artificial Intelligence
  • Software Only
  • Data & Analytics
Updated 8 days ago

Funding

Raised to date

$310MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

across 2 rounds

+6

$150M · Series C

Announced Sep 2026 · from article date

Disclosed cumulative: $310M

2/2

Founders

Founder details are not available yet.

Product

Problem

Getting a new medication from prescription to patient is slow and unreliable, with administrative steps like insurance authorization, financial assistance enrollment, and pharmacy routing creating significant delays. Even after FDA approval, many eligible patients never receive treatment due to a system not built for the complexity of modern medicine.

Solution

Forus provides an AI-powered network that automates every step between a clinical decision and a patient starting treatment, including prior authorizations, buy-and-bill support, appeal letters, enrollment forms, pharmacy routing, benefit verifications, and patient communication. The platform is free for doctors and patients, works with any EHR, and supports every drug, insurance, and pharmacy in all 50 states. By embedding into physician workflows, Forus reduces turnaround times from weeks to hours, allowing providers to reclaim clinical time. The network also provides biopharma companies with insights into how medicines perform, enabling better research, more effective drug launches, and investment in harder-to-treat conditions.

Target Audience

Primary users are healthcare providers, including physicians and practice staff, who need to reduce administrative burden and accelerate patient access to medications. The platform also serves biopharma companies seeking real-world insights into drug performance and launch effectiveness.

Features

  • Automated prior authorizations across pharmacy and medical benefits with payer-specific form completion
  • Customized appeal letters drafted based on specific denial reasons
  • Pharmacy routing to retail, specialty, or in-house pharmacies based on network status and preference
  • Personalized financial assistance enrollment with pre-populated intake forms for hub, bridge, and PAP programs
  • Real-time patient communication on PA status and medication readiness
  • AI-powered network connecting doctors, pharmacies, payers, and biopharma with unmatched insight into prescription movement
  • Works with any EHR for quick and lightweight setup
  • Supports every drug, insurance, and pharmacy in all 50 states
This profile is AI-generated and may contain inaccuracies.